⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid Methyl Ester SCHEMBL10879196 | 0.81 | ALDH1A1 (0.39) | — | |
| SCHEMBL15136162 | 0.77 | — | — | |
| SCHEMBL3086523 | 0.76 | CA1 (0.40) | — | |
| SCHEMBL13844418 | 0.76 | FUCA1 (0.31) | — | |
| SCHEMBL19084413 | 0.76 | — | — | |
| SCHEMBL5098364 | 0.76 | FUCA1 (0.31) | — | |
| SCHEMBL12166733 | 0.76 | CA1 (0.40) | — | |
| Methylamine SCHEMBL7555450 | 0.76 | FUCA1 (0.31) | — | |
| SCHEMBL12245492 | 0.76 | FUCA1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL2377228 | 0.74 | FUCA1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220274913-A1 | PROCESS FOR MANUFACTURING A SUBSTITUTED CYCLOHEXANECARBONITRILE | SOLVAY SA (BE) | 2022-09-01 | — | — | US | disclosed |
| EP-4028383-A1 | PROCESS FOR MANUFACTURING A SUBSTITUTED CYCLOHEXANECARBONITRILE | SOLVAY SA (BE) | 2022-07-20 | — | — | EP | disclosed |
| WO-2021048364-A1 | PROCESS FOR MANUFACTURING A SUBSTITUTED CYCLOHEXANECARBONITRILE | SOLVAY SA (BE) | 2021-03-18 | — | — | WO | disclosed |
| EP-3681463-B1 | SYNTHESIS AND USE OF 2-ETHYL-5,5-DIMETHYL-CYCLOHEXANOL AS FRAGRANCE AND FLAVOR MATERIAL | SYMRISE AG (DE) | 2021-03-03 | — | — | EP | disclosed |
| US-10435628-B2 | Polymerisable LC medium and polymer film with negative optical dispersion | MERCK PATENT GMBH (DE) | 2019-10-08 | — | — | US | disclosed |
| US-10403821-B2 | Method of making an electrode | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-09-03 | — | — | US | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20170194566-A1 | METHOD OF MAKING AN ELECTRODE | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-07-06 | — | — | US | disclosed |
| US-20120202766-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET, INC. (US) | 2012-08-09 | — | — | US | disclosed |
| US-8114997-B2 | N4-acylcytosine nucleosides for treatment of viral infections | PHARMASSET, INC. (US) | 2012-02-14 | — | — | US | disclosed |
| EP-1569652-A2 | N SP 4 /SP-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | Pharmasset Ltd. (BB) | 2005-09-07 | — | — | EP | disclosed |
| US-6908924-B2 | For therapy and prophylaxis of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts | PHARMASSET, INC. (US) | 2005-06-21 | — | — | US | disclosed |
| US-20040214844-A1 | N4-acylcytosine nucleosides for treatment of viral infections | GILEAD PHARMASSET LLC | 2004-10-28 | — | — | US | disclosed |
| EP-1461041-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | Pharmasset Ltd. (BB) | 2004-09-29 | — | — | EP | disclosed |
| CN-1463290-A | Method for prodn. of gasoline from gaseous hydrocarbon stock | INST NEFTECHIMICHESKOGO SINTEZ (RU) | 2003-12-24 | — | — | CN | disclosed |
| US-20030176319-A1 | For therapy and prophylaxis of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts | GILEAD PHARMASSET LLC | 2003-09-18 | — | — | US | disclosed |
| US-20030162992-A1 | Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde | PHARMASSET, INC. | 2003-08-28 | — | — | US | disclosed |
| WO-2003063771-A2 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | PHARMASSET LTD. (BB) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051306-A2 | N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |